VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $5,971,000 | +192.1% | 30,063 | +110.4% | 0.13% | +104.7% |
Q4 2014 | $2,044,000 | -49.0% | 14,286 | -53.2% | 0.06% | -31.2% |
Q3 2014 | $4,007,000 | -75.1% | 30,544 | -76.0% | 0.09% | -76.0% |
Q2 2014 | $16,070,000 | +1515.1% | 127,422 | +1589.1% | 0.39% | +1835.0% |
Q1 2014 | $995,000 | +80.3% | 7,544 | +60.3% | 0.02% | +122.2% |
Q4 2013 | $552,000 | +8.4% | 4,706 | -3.6% | 0.01% | -18.2% |
Q3 2013 | $509,000 | – | 4,880 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |